AzTrials
AzTrials

Suicide, AttemptedALGOSNCT01123174

Effectiveness of a Case Management Algorithm: ALGOS After a Suicide Attempt

A study testing ALGOS algorithm of case management in people with Suicide, Attempted, run by University Hospital, Lille at 23 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The suicidal behaviors are phenomena eminently multifactorial. It is thus always difficult to define univocal strategies of prevention of suicide repetition, during the emergency stay, i.e. almost in general population. One find 23 clinical trials in this topic in the past 25 years, and 18 are negative. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Suicide, Attempted
What is being tested?
ALGOS algorithm of case management
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,040 participants
Where
23 sitesFrance
Study dates
Feb 2010to Jul 2014
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Surviving to a suicide attempt (SA) directly leaving the Emergency unit or have been hospitalized less than 7 days

Who cannot join

  • recidivists who made 4 SA and more in the 3 past years

Trial locations and contacts

23 sites in 1 country.

23 sites in 1 country

France23 sites
  • University Hospital, Angers

    Angers

  • General Hospital, Boulogne sur Mer

    Boulogne-sur-Mer

  • University Hospital, Brest

    Brest

  • University Hospital, Caen

    Caen

  • University Hospital, Clermont Ferrand

    Clermont-Ferrand

  • Henri Mondor Hospital, Creteil

    Créteil

  • General Hospital, Douai

    Douai

  • General Hospital, Dunkerque

    Dunkirk

  • Health Centre Henin Beaumont

    Hénin-Beaumont

  • University Hospital, Lille

    Lille, 59037

  • University Hospital, Marseille

    Marseille

  • General Hospital, Montauban

    Montauban

  • University Hospital, Montpellier

    Montpellier

  • University Hospital, Nancy

    Nancy

  • University Hospital, Nantes

    Nantes

  • University Hospital, Nice

    Nice

  • Georges Pompidou European Hospital, Paris

    Paris

  • General Hospital, Quimper

    Quimper

  • University Hospital, Rennes

    Rennes

  • General Hospital, Roubaix

    Roubaix

  • University Hospital, Toulouse

    Toulouse

  • General Hospital, Tourcoing

    Tourcoing

  • General Hospital, Vannes

    Vannes

Other trials in France

About this study

Official title: Effectiveness of a "Case Management Algorithm" After a Suicide Attempt in Terms of Repetition of the Suicidal Behaviors and Medico-economic Impact

The suicidal behaviors are phenomena eminently multifactorial. It is thus always difficult to define univocal strategies of prevention of suicide repetition, during the emergency stay, i.e. almost in general population. One find 23 clinical trials in this topic in the past 25 years, and 18 are negative. The majority of the positive trials have the concern of being dissociated from an assumption of responsibility of care strictly speaking, to adopt a position "méta", nearer to the concept of "case management": how to remain in contact with the suicide attempter, without forcing it in this every day life, replacing a possible proposing, but assumption of responsibility resources reliable and quickly accessible in the event of at risk situation? Each one of these studies tests devices which seem more appropriate to such or such characteristic of this population, by retaining only simple criteria like the sex, the number of former suicide attempts, the proposal or not for an assumption of responsibility of care, the observance or not with the plan of care. Thus, it would seem interesting to combine these approaches in an algorithm entitled "ALGOS".

Main aim: To test the effectiveness of this algorithm of case management, named "ALGOS", in reducing the number of death by suicide, in terms of reduction of suicide re-attempts and the number of loss of contact patients in the ALGOS group during 6 months period, compared to a control group of suicide attempters treated as usual (i.e. primarily transmitted to the attending physician).

Read more

Secondary objectives: To evaluate, according to the method validated by Beecham in 1992, direct medico-economic impact in the year which follows the introduction of algorithm ALGOS. Reduction of the other suicidal behaviors in 6 months (reduction in the full number of suicidal repetitions in each group, evolution of the score of suicidal ideation, etc…). To evaluate the effect of the algorithm, at the 13th month. To study the possible differences within the time in terms of suicidal repetitions in the 2 groups. To propose different profiles of answers according to psychopathology, the number of suicide attempts, suicidal character, the sex,…

Methodology: Comparative simple blind prospective multicentric controlled study

Read the detailed description

Evaluations: The subjects will be included in the participating centers following a suicide attempt (SA). After checking of the criteria, information and signature of the study consent, the subjects will be randomized in one of the 2 groups (ALGOS versus Control). A fax of inclusion will be sent to the centralized research team of the Clinical Investigation Center (CIC) of Lille. All the subjects included will be then evaluated at the 6th month and 13th month after the SA, during a phone call. The final evaluation will be carried out in the current of the 13th month, so as to avoid a recontact at the time of the period birthday, too charged affectively at the majority with the patients. This phone call, personal, will be carried out by an trained psychologist. A mail preventing the subject of the call will be addressed approximately 10 days before. During the evaluations at the 6th month and 13th month, the number of suicidal repetitions will be reported, consumption of care since inclusion will be noted, the scale of suicidal ideation of Beck assessed, and a psychopathological evaluation carried out (Mini International Neuropsychiatric Interview DSM IV).

Being tested
ALGOS algorithm of case management
Keywords
Suicide, case management algorithm, suicidal behaviors, prevention of suicide
Medical subject headings
Suicide, Attempted, Suicide

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ALGOS algorithm of case managementBehavioural

    Also called ALGOS Group

    If the subject survives one 1st SA (first attempter): he leaves the center where he was included with a "chart resource" (crisis card) which contains addresses of the Web sites of associations of prevention of the suicide, as well as an accessible phone number 24/24h.

    If the subject is not a first attempter : he will be recontacted on the telephone between the 10th and the 21st day following the SA. If the subject is not contacted or little observing in the plan of care, it will receive a series of postcards then regularly, with 4 recoveries: to 2, 3, 4 and 5 months after the attempt.

Study groups in NCT01123174
Study groupRoleWhat they receive
ALGOS groupExperimentalAlgorithm of case management over the 6 months following the suicidal gesture (systematic telephone contact, postcards and crisis card)
Receives: Behavioral: ALGOS algorithm of case management
Control groupNo interventionTreatment as usual (referral back to the general practitioner)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of suicide re-attempters

    the number of suicide re-attempters 6 months following the attempt index

    Measured: six months

Secondary outcomes (7)
  1. Number of deaths per suicide

    Number of suicide re-attempts in the 6 months following the attempt index

    Measured: six months and 13 months

  2. Number of lost to follow up

    Measured: six months and 13 months

  3. Number of suicide re-attempters

    Measured: 13 months

  4. Number of suicide re-attempts

    Number of suicide re-attempts in the 6 months following the attempt index

    Measured: six months and 13 months

  5. Suicidal ideation intensity

    The suicidal ideation will be measured by Scale of Suicidal Ideation (A. Beck, M. Kovacs, and A. Weissman, 1979) in the 6 months following the attempt index and in the 13 months.

    Measured: six months and 13 months

  6. medical cost

    Numbers of hospitalisations, numbers of consultations, and drugs consummation during the year following the suicide attempt will be measured to estimate the medical cost

    Measured: six months and one year

  7. Evaluation of the psychopathological profile

    The psychopathological profile will be evaluated by the French version of Mini International Neuropsychiatric Interview (DSM IV)

    Measured: six months and 13 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 May 2010 (estimated)
  2. Study startFeb 2010
  3. Primary completionJul 2014
  4. Study completionJul 2014

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
1,040 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01123174
Sponsor's protocol ID
2009_25
Other IDs
PHRC 2009/1902, 2009-A00893-54
Acronym
ALGOS
Status last verified
Jun 2015
First submitted
18 Mar 2010
Last updated
14 May 2026
Results posted
No
Data monitoring committee
No

Publications

  • Vaiva G, Vaiva G, Ducrocq F, Meyer P, Mathieu D, Philippe A, Libersa C, Goudemand M. Effect of telephone contact on further suicide attempts in patients discharged from an emergency department: randomised controlled study. BMJ. 2006 May 27;332(7552):1241-5. doi: 10.1136/bmj.332.7552.1241.

    PubMed 16735333
  • Carter GL, Clover K, Whyte IM, Dawson AH, D'Este C. Postcards from the EDge project: randomised controlled trial of an intervention using postcards to reduce repetition of hospital treated deliberate self poisoning. BMJ. 2005 Oct 8;331(7520):805. doi: 10.1136/bmj.38579.455266.E0. Epub 2005 Sep 23.

    PubMed 16183654
  • Evans J, Evans M, Morgan HG, Hayward A, Gunnell D. Crisis card following self-harm: 12-month follow-up of a randomised controlled trial. Br J Psychiatry. 2005 Aug;187:186-7. doi: 10.1192/bjp.187.2.186.

    PubMed 16055834
  • Vaiva G, Walter M, Al Arab AS, Courtet P, Bellivier F, Demarty AL, Duhem S, Ducrocq F, Goldstein P, Libersa C. ALGOS: the development of a randomized controlled trial testing a case management algorithm designed to reduce suicide risk among suicide attempters. BMC Psychiatry. 2011 Jan 2;11:1. doi: 10.1186/1471-244X-11-1.

    PubMed 21194496
  • Demesmaeker A, Chazard E, Vaiva G, Amad A. Risk Factors for Reattempt and Suicide Within 6 Months After an Attempt in the French ALGOS Cohort: A Survival Tree Analysis. J Clin Psychiatry. 2021 Feb 18;82(1):20m13589. doi: 10.4088/JCP.20m13589.

    PubMed 33999539
  • Witt KG, Hetrick SE, Rajaram G, Hazell P, Taylor Salisbury TL, Townsend E, Hawton K. Psychosocial interventions for self-harm in adults. Cochrane Database Syst Rev. 2021 Apr 22;4(4):CD013668. doi: 10.1002/14651858.CD013668.pub2.

    PubMed 33884617
  • Vaiva G, Berrouiguet S, Walter M, Courtet P, Ducrocq F, Jardon V, Larsen ME, Cailhol L, Godesense C, Couturier C, Mathur A, Lagree V, Pichene C, Travers D, Lemogne C, Henry JM, Jover F, Chastang F, Prudhomme O, Lestavel P, Gignac CT, Duhem S, Demarty AL, Mesmeur C, Bellivier F, Labreuche J, Duhamel A, Goldstein P. Combining Postcards, Crisis Cards, and Telephone Contact Into a Decision-Making Algorithm to Reduce Suicide Reattempt: A Randomized Clinical Trial of a Personalized Brief Contact Intervention. J Clin Psychiatry. 2018 Sep 25;79(6):17m11631. doi: 10.4088/JCP.17m11631.

    PubMed 30256552

Questions about this trial

What is this clinical trial studying?

A study testing ALGOS algorithm of case management in people with Suicide, Attempted, run by University Hospital, Lille at 23 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 23 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of suicide re-attempters (time frame: six months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01123174, which also lists 7 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 May 2026; AzTrials last refreshed its copy on 29 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in